Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue.

Unger FT, Lange N, Krüger J, Compton C, Moore H, Agrawal L, Juhl H, David KA.

J Transl Med. 2016 Jan 8;14:6. doi: 10.1186/s12967-015-0752-1.

2.

Metabolomics profiling of pre-and post-anesthesia plasma samples of colorectal patients obtained via Ficoll separation.

Ghini V, Unger FT, Tenori L, Turano P, Juhl H, David KA.

Metabolomics. 2015;11(6):1769-1778. doi: 10.1007/s11306-015-0832-5. Epub 2015 Jul 25.

3.

Identification and Validation of a Potential Marker of Tissue Quality Using Gene Expression Analysis of Human Colorectal Tissue.

Lange N, Unger FT, Schöppler M, Pursche K, Juhl H, David KA.

PLoS One. 2015 Jul 29;10(7):e0133987. doi: 10.1371/journal.pone.0133987. eCollection 2015.

4.

Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue.

David KA, Unger FT, Uhlig P, Juhl H, Moore HM, Compton C, Nashan B, Dörner A, de Weerth A, Zornig C.

Oncotarget. 2014 Nov 30;5(22):11017-28. doi: 10.18632/oncotarget.2669.

5.

Prediction of individual response to anticancer therapy: historical and future perspectives.

Unger FT, Witte I, David KA.

Cell Mol Life Sci. 2015 Feb;72(4):729-57. doi: 10.1007/s00018-014-1772-3. Epub 2014 Nov 12. Review.

6.

DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells.

Unger FT, Klasen HA, Tchartchian G, de Wilde RL, Witte I.

BMC Cancer. 2009 Oct 10;9:359. doi: 10.1186/1471-2407-9-359.

Supplemental Content

Loading ...
Support Center